300871.SZ SHZ
Hvsen Biotechnology Co., Ltd.
1W: -2.8%
1M: -6.4%
3M: -9.7%
YTD: -22.1%
1Y: -7.9%
3Y: +27.2%
5Y: -48.0%
¥21.10 ($3.15)
+0.48 (+2.33%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥4.3B ($635.1M)
52W Range19.08-32.62
Volume4,093,621
Avg Volume6,191,169
Beta0.59
Dividend¥0.30
Analyst Ratings
No analyst coverage
Company Info
CEOJie Han
Employees1,133
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-24
Websitewhhsyy.com
No.208 Zhangbai Road
Wuhan, HB 430042
CN
Wuhan, HB 430042
CN
86 27 8323 5399
About Hvsen Biotechnology Co., Ltd.
Hvsen Biotechnology Co., Ltd. is a company based in Wuhan, China, that focuses on the global research, development, and manufacturing of macrolide active pharmaceutical ingredients (APIs) and finished drug products. The company's diverse product portfolio features tylvalosin, offered in both raw material form and various preparations, along with florfenicol preparations and a broader selection of other macrolide-based offerings. Additionally, Hvsen produces a range of veterinary pharmaceuticals, available as both raw ingredients and finished drugs, alongside traditional Chinese medicine extracts.
Latest News
No recent news
Recent Insider Trades
No insider trades found